Featured Research

from universities, journals, and other organizations

Natural Approach To Immune Regulation May Help Transplant Patients

Date:
July 11, 2006
Source:
Medical College of Georgia
Summary:
A molecule expressed during pregnancy seems to turn down the immune system, making it more tolerant of welcome visitors such as a fetus or maybe a transplanted heart, researchers say.

Dr. Anatolij Horuzsko, MCG reproductive immunologist.
Credit: Image courtesy of Medical College of Georgia

A molecule expressed during pregnancy seems to turn down the immune system, making it more tolerant of welcome visitors such as a fetus or maybe a transplanted heart, researchers say.

Human leukocyte antigen G, or HLA-G, is a member of a gene family called major histocompatibility complex that provokes an immune response, says Dr. Anatolij Horuzsko, reproductive immunologist at the Medical College of Georgia.

Like an errant child, HLA-G instead promotes tolerance, and researchers have found it can even make other gene family members more accepting, says Dr. Horuzsko, who is presenting his research during the Fourth International Conference on HLA-G July 10-13 in Paris and chairing a session on structure and receptor interaction. His research also is featured in the August issue of the European Journal of Immunology.

The placenta expresses HLA-G from the earliest stages of embryo implantation and the molecule goes away toward the end of pregnancy. Growth factors and cytokines – signaling compounds involved in the development and function of the immune system – bring to the surface inhibitory receptors previously buried inside immune cells so they can interact with the HLA-G.

Amazingly, scientists have documented this natural immunosuppression, to a lesser extent, in at least one more situation: when an organ is transplanted. Dr. Horuzsko wants to augment this natural process so transplant patients won’t require a lifetime of generalized immune suppression that puts them at risk for many other diseases.

He has created animal models in which these inhibitory receptors are expressed on the cell surface. Using the same mixture the body uses – cytokines and growth factors – he also gets the receptors expressed on the surface of human cells in a test tube. He gives HLA-G in both situations and studies the response.

In dendritic cells, major orchestrators of the immune response, he has watched how activated inhibitory receptors down-regulate the function of stimulators of the immune response also present on the cell surface. Interestingly, the targets are members of the major histocompatibility complex family to which HLA-G belongs.

“These dendritic cells are not defective, but they develop tolerogenic properties, which are not normal for them,” says Dr. Horuzsko, who equates modifying the immune response to turning down the volume of a television. “We think we can help them into a tolerogenic pathway by giving HLA-G and get them to ignore the antigen coming from transplanted tissue,” he says. Unfortunately, he notes, cancer and some viruses seem capable of similar manipulation.

Using this approach, he has been able to prolong acceptance of skin grafts, which are typically rapidly rejected, sometimes indefinitely.

He’s also getting T cells, another major player in the immune response, to express inhibitory receptors. Normally dendritic cells show an invader to T cells which produce cytotoxic T cells to destroy it. But when T cells express the inhibitory receptor, they go silent and may even die.

A long list of other cells that provoke an immune response might be “kept under control” by this approach, Dr. Horuzsko says.

He envisions, in the not too distant future, giving cytokines and growth factors to patients so targeted cells will express inhibitory receptors then delivering a sort of HLA-G manufacturing plant, probably blood-derived stem cells modified to produce it. In patients who already express inhibitory receptors, it may be enough to give only HLA-G. Dr. Horuzsko plans to further investigate this expression that occurs soon after an organ transplant in some patients.

These natural approaches would be used to prepare a patient for transplant and activated when problems with rejection emerge.

“I believe this natural mechanism is a very powerful tool for protecting tissue allografts from rejection,” says Dr. Horuzsko.

The research is funded by the National Institutes of Health and the Roche Organ Transplantation Research Foundation.


Story Source:

The above story is based on materials provided by Medical College of Georgia. Note: Materials may be edited for content and length.


Cite This Page:

Medical College of Georgia. "Natural Approach To Immune Regulation May Help Transplant Patients." ScienceDaily. ScienceDaily, 11 July 2006. <www.sciencedaily.com/releases/2006/07/060711091304.htm>.
Medical College of Georgia. (2006, July 11). Natural Approach To Immune Regulation May Help Transplant Patients. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2006/07/060711091304.htm
Medical College of Georgia. "Natural Approach To Immune Regulation May Help Transplant Patients." ScienceDaily. www.sciencedaily.com/releases/2006/07/060711091304.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins